The value of leukopenia during the first hour of admission as a prognostic marker in meningococcal infection;Valor de la leucopenia durante la primera hora como marcador pronóstico en la enfermedad meningococcica

Revista Chilena de Pediatria

Volumn 75, Issue 5, 2004, Pages 441-447

  Donoso F, Alejandro ^a   León B, José ^a   Rojas A, Gloria ^a   Ramírez A, Milena ^a   Oberpaur W, Bernd ^a  

^a HOSPITAL PADRE HURTADO   (Chile)

Author keywords

Leukopenia; Meningococcal disease; Prognosis; Purpura fulminans; White blood cell

Indexed keywords

ARTICLE; BACTERIAL INFECTION; CHILD; CHILD HOSPITALIZATION; COHORT ANALYSIS; DISEASE COURSE; FULMINATING PURPURA; HOSPITAL ADMISSION; HUMAN; INFANT; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; PROGNOSIS; PROSPECTIVE STUDY;

EID: 10044271056     PISSN: 03704106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MINSAL: Departamento de Epidemiología. Vigilancia Epidemiológica. Enfermedad Meningocóccica. Semana 28 (2004).
2. Baines PB, Hart CA: Severe meningococcal disease in childhood. Br J Anaesth 2003; 90: 72-83.
3. Kennedy N, Duncan AW: Acute meningococcaemia: Recent advance in management (with particular reference to children). Anaesth Intens Care 1996; 24: 197-216.
4. Stiehm ER, Damrosh DS: Factors in the prognosis of meningococcal infection. J Pediatr 1966; 68: 457-67.
5. Niklasson PM, Lundbergh P, Strandell T: Prognostic factors in meningococcal disease. Scand J Infect Dis 1971; 3: 17-25.
6. Ledere F, Beuscart R, Guillois B, et al: Prognostic factors of severe infectious purpura in children. Intensive Care Med 1985; 11: 140-3.
7. Tesoro LJ, Selbst SM: Factors affecting outcome in meningococcal infections. Am J Dis Child 1991; 145: 218-20.
8. Algren JT, Lal S, Cutliff SA, Richman BJ: Predictors of outcome in acute meningococcal infection in children. Crit Care Med 1993; 21: 447-53.
9. Lodder MC, Schildkamp RL, Bijlmer HA, Dankert J. Kuik DJ, Scholten RJ: Prognostic indicators of the outcome of meningococcal disease: a study of 562 patients. J Med Microbiol 1996; 45: 16-20.
10. Malley R, Huskins W, Kuppermann N: Multivariable predictive models for adverse outcome of invasive meningococcal disease in children. J Pediatr 1996; 129: 702-10.
11. Nürnberger W, Platonov A, Stannigel H, et al: Definition of a new score for severity of generalised Neisseria meningitidis infection. Eur J Paediatr 1995; 154: 896-900.
12. Sinclair JF, Skeoch CH, Hallworth D: Prognosis of meningococcal septicaemia. Lancet 1987; 38.
13. Emparanza JL, Aldamiz-Echevarría L, Pérez-Yarza EG, et al: Prognostic score in acute menigococcemia. Crit Care Med 1988; 16: 168-9.
14. Thompson A, Sills J, Hart C: Validation of the Glasgow Meningococcal Septicemia prognostic score: a 10-year retrospective survey. Crit Care Med 1991; 19: 26-30.
15. Hachimi-Idrissi S, Corne L, Ramet J: Evaluation of scoring systems in acute meningococcaemia. Eur J Emerg Med 1998; 5: 225-30.
16. Castellanos-Ortega A, Delgado-Rodríguez M, Llorca J, et al: A new prognostic scoring system for meningococcal septic shock in children. Comparison with three other scoring systems. Intensive Care Med 2002; 28: 341-51.
17. Cárdenas A, Contreras A, Rojas C: Pronóstico en niños con enfermedad meningococcca. Rev Chil Pediatr 1985; 66: 118-20.
18. Donoso A, Valverde C, Clavería C, et al: Empleo del score de NESI (Neisseria sepsis index) en meningococcemia aguda. Rev Chil Pediatr 2001; 72: 301-7.
19. Peters MJ, Ross,-Russell R, White D, et al: Early severe neutropenia and thrombocytopenia identifies the highest risk cases of severe meningococcal disease. Pediatric Crit Care Med 2001; 2: 225-31.
20. Pathan N, Faust SN, Levin M: Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child 2003; 88: 601-7.
21. Klein NJ, Levin M, Strobel S, Finn A: Degradation of glycosaminoglycans and fibronectin on endotoxin-stimulated endothelium by adherent neutrophils: relationship to CD11b/CD18 and L-selectin expression. J Infect Dis 1993; 167: 890-8.
22. Oragui EE, Nadel S, Kyd P, Levin M: Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria. Crit Care Med 2000; 28: 3002-8.
23. Klein NJ, Shennan GI, Heyderman RS, Levin M: Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci 1992; 102: 821-32.
24. Llinares Tello F, Hernández Prats C, Burgos San José A, et al: Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients. J Med Microbiol 1996; 45: 16-20.
25. Bachli EB, Vavricka SR, Walter RB, Leschinger MI, Maggiorini M: Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans. Intensive Care Med 2003; 29: 337.
26. Weisel G, Joyce D, Gudmundsdottir A, Shasby DM: Human recombinant activated protein C in meningococcal sepsis. Chest 2002; 121: 292-5.
27. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP: An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2001; 96: 3719-24.
28. Munteanu C, Bloodworth L, Korn T: Antithrombin concentrate with plasma exchange in purpura fulminans. Pediatr Crit Care Med 2000; 1: 84-7.
29. Goldman AP, Kerr SJ, Butt W, et al: Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349: 466-9.
30. McMaster P, Shann F: The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr Crit Care Med 2003; 4: 2-7.
31. Ringe HI, Varnholt V, Gaedicke G: Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediatr Crit Care Med 2003; 4: 471-5.
32. Levin M, Quint PA, Goldstein B, et al: Recombinant bactericidal/ permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 2000; 356: 961-7.
33. de Kleijn ED, de Groot R, Hack CE, et al: Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003; 31: 1839-47.